Heathers G P, Yamada K A, Kanter E M, Corr P B
Department of Internal Medicine, Washington University, School of Medicine, St. Louis, MO 63110.
Circ Res. 1987 Nov;61(5):735-46. doi: 10.1161/01.res.61.5.735.
To elucidate the mechanisms responsible for the increase in alpha 1-adrenergic receptors during ischemia in vivo, we developed a procedure for measuring alpha 1-adrenergic receptors in isolated, calcium-tolerant adult canine myocytes. Specific [3H]prazosin binding was rapid, saturable, reversible, and demonstrated the expected order of potency and stereospecificity for the alpha 1-adrenergic receptor. Myocytes exposed to 30 minutes of hypoxia at 25 degrees C or only 10 minutes at 37 degrees C exhibited a twofold to threefold increase in the number of alpha 1-adrenergic receptors with no significant change in receptor affinity. This hypoxia-induced increase in receptor number was reversible by 10 minutes of reoxygenation at 37 degrees C. In contrast, more prolonged hypoxia of 80 minutes or hypotonic shock actually decreased receptor number below normoxic, control values. The concentration of long-chain acylcarnitines in myocytes also increased threefold on exposure to 30 minutes of hypoxia. Sodium 2-[5-(4-chlorophenyl)-pentyl]-oxirane-2-carboxylate (POCA, 10 microM), a potent inhibitor of carnitine acyltransferase I, not only abolished the accumulation of long-chain acylcarnitines but also the increase in alpha 1-adrenergic receptor number induced by 30 minutes of hypoxia. Likewise, incubation of normoxic cells with exogenous palmitoyl carnitine (1 microM) for 10 minutes also increased alpha 1-adrenergic receptor number in the presence or absence of POCA. Thus, hypoxia results in an increase in alpha 1-adrenergic receptors associated with an increase in endogenous long-chain acylcarnitines. Furthermore, inhibition of carnitine acyltransferase I prevents not only the sarcolemmal accumulation of long-chain acylcarnitines but also the exposure of the alpha 1-adrenergic receptor, indicating that accumulation of endogenous long-chain acylcarnitines is critical to the hypoxia-induced increase in alpha 1-adrenergic receptors on adult myocytes.
为阐明体内缺血期间α1 - 肾上腺素能受体增加的机制,我们开发了一种用于测量分离的、耐钙成年犬心肌细胞中α1 - 肾上腺素能受体的方法。特异性[3H]哌唑嗪结合迅速、可饱和、可逆,并显示出α1 - 肾上腺素能受体预期的效价顺序和立体特异性。在25℃下暴露于30分钟缺氧或仅在37℃下暴露10分钟的心肌细胞,其α1 - 肾上腺素能受体数量增加了两倍至三倍,而受体亲和力无显著变化。这种缺氧诱导的受体数量增加在37℃下复氧10分钟后是可逆的。相比之下,80分钟的更长时间缺氧或低渗休克实际上使受体数量降至低于常氧对照值。暴露于30分钟缺氧后,心肌细胞中长链酰基肉碱的浓度也增加了三倍。肉碱酰基转移酶I的强效抑制剂2 - [5 - (4 - 氯苯基)-戊基]-环氧乙烷 - 2 - 羧酸钠(POCA,10 microM)不仅消除了长链酰基肉碱的积累,也消除了30分钟缺氧诱导的α1 - 肾上腺素能受体数量增加。同样,在有或没有POCA的情况下,用外源性棕榈酰肉碱(1 microM)孵育常氧细胞10分钟也增加了α1 - 肾上腺素能受体数量。因此,缺氧导致α1 - 肾上腺素能受体增加,同时内源性长链酰基肉碱增加。此外,抑制肉碱酰基转移酶I不仅阻止长链酰基肉碱在肌膜的积累,也阻止α1 - 肾上腺素能受体的暴露,表明内源性长链酰基肉碱的积累对成年心肌细胞缺氧诱导的α1 - 肾上腺素能受体增加至关重要。